Everything tagged "turnaround" across research, earnings, and macro.
48 articles
Lululemon’s latest reset looks less like a bad consumer backdrop and more like a company-specific U.S. execution problem. The stock is cheap on paper, but a flat-to-down revenue outlook and collapsing North America momentum make that valuation look like a trap, not an opportunity.
Medtronic finally has a growth story that looks big enough to matter at the company level, not just in a niche product line. With cardiac ablation surging and valuation still well below faster-loved device peers, MDT looks like the more compelling catch-up trade here.
Medtronic is showing its strongest top-line growth in a decade, led by cardiovascular and pulsed field ablation momentum. The stock looks like a balanced Buy for moderate-risk investors, though margin pressure and debt keep the turnaround case from being pristine.
Macy’s is a disciplined value turnaround with improving comps, strong cash generation, and better momentum in Bloomingdale’s and Bluemercury. Tariff pressure and a still-declining revenue base keep the setup selective, but the stock looks inexpensive versus earnings and cash flow.
Dollar General is showing a real operational recovery, with positive traffic, improving margins, and a valuation that looks more reasonable than it did a year ago. The stock remains a turnaround story, but the latest results suggest the repair effort is starting to stick.
Dollar Tree is emerging as a cleaner single-banner retailer with improving comps, margin gains, and raised guidance. The stock still looks reasonably priced if management can sustain traffic and execution.
Capri is now a simpler two-brand luxury business after selling Versace and cutting net debt sharply. Low valuation, improving margins, and a return to profitability support a Hold case, but revenue is still declining.
Skyworks looks like more than a dead-cat bounce after its May earnings beat and a disclosed Android program worth more than $1 billion through 2030. The one-customer risk is still real, but the market is finally pricing in evidence that the business may be broadening faster than bears expected.
Nio’s Q1 2026 results showed a real operating inflection, with revenue up 112.2% and gross margin expanding to 19.0%. The stock still carries heavy losses and leverage, but the company’s three-brand strategy and battery-swapping edge support a selective Buy view.
Estée Lauder's failed Puig talks look like a positive, not a setback. With M&A noise gone, the market can focus on a turnaround that is finally showing up in margins, China trends, and repeated earnings beats.
Advance Auto Parts is showing early turnaround progress with improving comps, margins, and EPS in 2026. The stock still carries leverage and uneven cash flow, but the setup offers upside if execution continues.
LuxExperience is a selective Buy turnaround story: Mytheresa is compounding while the YNAP assets improve from drag to repair. The stock screens cheap at 0.37x revenue, but execution and cash burn still matter.
Generate AI research on any ticker — grades, price targets, and full analysis in minutes.
Open the Generator